Hepatocellular carcinoma (HCC), the most common form of primary liver cancer, is undergoing a significant transformation in ...

The increasing prevalence of HCC is driving the hepatocellular carcinoma treatment market growth. According to estimates, more than 1 million people will be affected with hepatocellular carcinoma ...

Warrior Met Coal, Inc. engages in the production and export of non-thermal steelmaking coal for the steel production by metal manufacturers in Europe, South America, and Asia. The company offers ...

With a more normalized/subdued steel market and the capital investment required for Blue Creek, I think HCC can grow their book value by 10% over the next 5 years without having to dilute ...

We came across a bullish thesis on Warrior Met Coal, Inc. (HCC) on Substack by Margin of Sanity. In this article, we will summarize the bulls’ thesis on HCC. Warrior Met Coal, Inc. (HCC)’s share was ...

EMA Orphan Drug Designation (ODD) builds on U.S. Food & Drug Administration (FDA) ODD and Fast Track Designation, underscoring the urgen ...

Investing.com -- Shares of Tempest Therapeutics Inc (NASDAQ: TPST) climbed 5.3% following the announcement that the European Medicines Agency (EMA) has granted Orphan Drug Designation to its cancer ...

In a challenging market environment, Warrior Met Coal Inc (NYSE: HCC) stock has reached a 52-week low, dipping to $45.91.According to InvestingPro analysis, the company maintains strong financial ...

Market Capitalization Reflects the total market value of a company. Market Cap is calculated by multiplying the number of shares outstanding by the stock's price. For companies with multiple ...

Sources: FactSet, Dow Jones Stock Movers: Gainers, decliners and most actives market activity tables are a combination of NYSE, Nasdaq, NYSE American and NYSE Arca listings. Sources: FactSet ...